Literature DB >> 8809045

Two regulatory elements of similar structure and placed in tandem account for the repressive activity of the first intron of the human apolipoprotein A-II gene.

J P Bossu1, F L Chartier, J C Fruchart, J Auwerx, B Staels, B Laine.   

Abstract

Recent reports indicate that apolipoprotein (apo) A-II, the second most abundant protein of high-density lipoproteins, plays a crucial role in counteracting the beneficial effect of apo A-I against atherogenesis. Transcription of the human apo A-II gene is controlled by an enhancer comprising 14 regulatory elements located upstream of its promoter whereas the first intron of this gene behaves as a silencer. Here we show that two sequence elements account for the repressive activity of this intron and correspond to negative regulatory elements termed NRE I and NRE II. The activity of intron I and the nuclear proteins binding to NRE I and II are encountered in hepatic cells but not in non-hepatic cells studied here. Both NREs form nucleoprotein complexes of very similar physicochemical characteristics and bind the same or closely related proteins. Site-directed mutagenesis, transient transfection and gel-shift analysis experiments indicate that both NREs exhibit similar structures, being composed of two sites required for maximal activity and optimal binding of transcription factors. Therefore two negative regulatory elements of similar structure and function, placed in tandem, account for the repressive activity of the first intron of the human apo A-II gene. These NREs do not exhibit structural similarity with known NREs of other genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809045      PMCID: PMC1217655          DOI: 10.1042/bj3180547

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Identification of two silencers flanking an AP-1 enhancer in the vimentin promoter.

Authors:  F A van de Klundert; G J van Eldik; F R Pieper; H J Jansen; H Bloemendal
Journal:  Gene       Date:  1992-12-15       Impact factor: 3.688

Review 2.  Genetics of lipoprotein disorders.

Authors:  J L Breslow
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

3.  Factors participating in the liver-specific expression of the human apolipoprotein A-II gene and their significance for transcription.

Authors:  P Cardot; J Chambaz; D Kardassis; C Cladaras; V I Zannis
Journal:  Biochemistry       Date:  1993-09-07       Impact factor: 3.162

4.  Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.

Authors:  C H Warden; C C Hedrick; J H Qiao; L W Castellani; A J Lusis
Journal:  Science       Date:  1993-07-23       Impact factor: 47.728

5.  Transcription of the human apolipoprotein A-II is down-regulated by the first intron of its gene.

Authors:  J P Bossu; F L Chartier; N Vu-Dac; J C Fruchart; B Laine
Journal:  Biochem Biophys Res Commun       Date:  1994-07-29       Impact factor: 3.575

6.  Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.

Authors:  J R Schultz; J G Verstuyft; E L Gong; A V Nichols; E M Rubin
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

7.  Multiple silencer elements are involved in regulating the chicken vimentin gene.

Authors:  R J Garzon; Z E Zehner
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

8.  A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer.

Authors:  M de la Llera Moya; V Atger; J L Paul; N Fournier; N Moatti; P Giral; K E Friday; G Rothblat
Journal:  Arterioscler Thromb       Date:  1994-07

9.  Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.

Authors:  C C Hedrick; L W Castellani; C H Warden; D L Puppione; A J Lusis
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

10.  Identification of a cis-acting negative DNA element which modulates human hepatic triglyceride lipase gene expression.

Authors:  M Hadzopoulou-Cladaras; P Cardot
Journal:  Biochemistry       Date:  1993-09-21       Impact factor: 3.162

View more
  6 in total

1.  The activity of the activation function 2 of the human hepatocyte nuclear factor 4 (HNF-4alpha) is differently modulated by F domains from various origins.

Authors:  L Suaud; P Formstecher; B Laine
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  4-Phenylbutyrate stimulates Hsp70 expression through the Elp2 component of elongator and STAT-3 in cystic fibrosis epithelial cells.

Authors:  Laurence Suaud; Katelyn Miller; Ashley E Panichelli; Rachel L Randell; Catherine M Marando; Ronald C Rubenstein
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

Review 3.  Transcriptional control and the role of silencers in transcriptional regulation in eukaryotes.

Authors:  S Ogbourne; T M Antalis
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

Review 4.  Long-Distance Repression by Human Silencers: Chromatin Interactions and Phase Separation in Silencers.

Authors:  Ying Zhang; Yi Xiang See; Vinay Tergaonkar; Melissa Jane Fullwood
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

5.  The G115S mutation associated with maturity-onset diabetes of the young impairs hepatocyte nuclear factor 4alpha activities and introduces a PKA phosphorylation site in its DNA-binding domain.

Authors:  Bénédicte Oxombre; Mostafa Kouach; Ericka Moerman; Pierre Formstecher; Bernard Laine
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

6.  Developing a set of strong intronic promoters for robust metabolic engineering in oleaginous Rhodotorula (Rhodosporidium) yeast species.

Authors:  Yanbin Liu; Sihui Amy Yap; Chong Mei John Koh; Lianghui Ji
Journal:  Microb Cell Fact       Date:  2016-11-25       Impact factor: 5.328

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.